dc.contributor.author |
Salvador-Oke, Kafilat Taiwo
|
|
dc.contributor.author |
Pitout, Johann D.D.
|
|
dc.contributor.author |
Peirano, Gisele
|
|
dc.contributor.author |
Strydom, Kathy-Anne
|
|
dc.contributor.author |
Kingsburgh, Chanel
|
|
dc.contributor.author |
Ehlers, Marthie Magdaleen
|
|
dc.contributor.author |
Kock, Marleen M.
|
|
dc.date.accessioned |
2024-10-22T06:34:07Z |
|
dc.date.available |
2024-10-22T06:34:07Z |
|
dc.date.issued |
2024-09 |
|
dc.description |
DATA AVAILABILITY :
No datasets were generated or analysed during the current study. |
en_US |
dc.description.abstract |
This study investigated the molecular characteristics of urinary carbapenemase-producing Klebsiella pneumoniae isolates (n = 194) in Gauteng, South Africa, using simple, cost-effective PCR methodologies. Extensively drug resistant (XDR) ST307 with blaOXA-181 on IncX3 plasmids was endemic in Gauteng community hospitals leaving limited options for treating in- and outpatient urinary tract infections. High-level ceftazidime/avibactam resistance was detected among isolates harbouring blaOXA-48-like including blaOXA-181. These findings highlighted the need for genomic methodologies suitable for lower- and middle-income countries to track XDR clones and plasmids in community hospitals. Such results will aid with treatment and stewardship strategies. |
en_US |
dc.description.department |
Medical Microbiology |
en_US |
dc.description.librarian |
hj2024 |
en_US |
dc.description.sdg |
SDG-03:Good heatlh and well-being |
en_US |
dc.description.sponsorship |
The National Research Foundation (NRF) of South Africa; Competitive Support for Unrated Researchers and the University of Pretoria (PhD student bursary, 2022). Open access funding provided by University of Pretoria. |
en_US |
dc.description.uri |
https://link.springer.com/journal/10096 |
en_US |
dc.identifier.citation |
Salvador-Oke, K.T., Pitout, J.D.D., Peirano, G. et al. Klebsiella pneumoniae with carbapenemases: high prevalence of sequence type 307 with blaOXA181 in South African community hospitals. European Journal of Clinical Microbiology & Infectious Diseases (2024). https://doi.org/10.1007/s10096-024-04947-z. |
en_US |
dc.identifier.issn |
0934-9723 (print) |
|
dc.identifier.issn |
1435-4373 (online) |
|
dc.identifier.other |
10.1007/s10096-024-04947-z |
|
dc.identifier.uri |
http://hdl.handle.net/2263/98695 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Springer |
en_US |
dc.rights |
© The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. |
en_US |
dc.subject |
Klebsiella pneumoniae |
en_US |
dc.subject |
Gauteng Province, South Africa |
en_US |
dc.subject |
Extensively drug resistant (XDR) |
en_US |
dc.subject |
Carbapenemase-producing Klebsiella pneumoniae |
en_US |
dc.subject |
High-risk clone ST307 |
en_US |
dc.subject |
IncX3 plasmid |
en_US |
dc.subject |
bla OXA-181 |
en_US |
dc.subject |
Low- and middle-income countries (LMICs) |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.title |
Klebsiella pneumoniae with carbapenemases : high prevalence of sequence type 307 with blaOXA181 in South African community hospitals |
en_US |
dc.type |
Article |
en_US |